Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 17/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8330132 | 0.77 | LMNA (0.38) | LMNAFDPSMMP2 | |
| SCHEMBL3981963 | 0.71 | LMNA (0.47) | LMNAFDPS | |
| Phosphoric Acid SCHEMBL28801115 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL21359160 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL16093844 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL192007 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL9359318 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL1019439 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| Phosphoric Acid SCHEMBL192006 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 | |
| N,N-Dimethylethanaminium SCHEMBL9049895 | 0.67 | FDPS (0.46) | LMNAFDPSMMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150362507-A1 | System and Methods of Detecting and Demonstrating Ultraviolet Damage to Hair Via Evaluation of Protein Fragments | THE PROCTER & GAMBLE COMPANY | 2015-12-17 | — | — | US | disclosed |
| US-7597720-B2 | Oxidizing hair colourant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2009-10-06 | — | — | US | disclosed |
| US-20090119852-A1 | Oxidizing Hair Colourant Compositions | WELLA OPERATIONS US, LLC | 2009-05-14 | — | — | US | disclosed |
| US-20070107143-A1 | Oxidative treatment of hair with reduced hair damage | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-17 | — | — | US | disclosed |
| US-7179302-B2 | Oxidative treatment of hair with reduced hair damage | THE PROCTER & GAMBLE COMPANY (US) | 2007-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070107143-A1 | Oxidative treatment of hair with reduced hair damage | KRT18, GPX4, COX5A | LMNA 667/4885FDPS 4569/4885MMP1 710/4885 |
| US-20090119852-A1 | Oxidizing Hair Colourant Compositions | TET1, TET2, TET3 | LMNA 4051/4885FDPS 2877/4885MMP1 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.